Published in Br J Ophthalmol on October 22, 2010
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond) (2013) 1.67
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard. PLoS One (2012) 1.38
Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets. Br J Pharmacol (2012) 1.06
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review. BMJ Open (2014) 0.89
Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity. PLoS One (2015) 0.81
Comparison of systemic adverse events associated with intravitreal anti-VEGF injection: ranibizumab versus bevacizumab. J Korean Med Sci (2012) 0.79
Effect of intravitreal anti-vascular endothelial growth factor therapy on the risk of arterial thromboembolic events: a meta-analysis. PLoS One (2012) 0.78
Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews? Ophthalmology (2016) 0.77
The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews. Indian J Ophthalmol (2014) 0.77
A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema. CADTH Technol Overv (2013) 0.77
A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus. BMC Ophthalmol (2012) 0.76
5.7 Times more expensive than liquid gold. Br J Ophthalmol (2011) 0.76
Safety and complications of intravitreal injections performed in an Asian population in Singapore. Int Ophthalmol (2016) 0.76
Today and future of age-related macular degeneration. ISRN Ophthalmol (2012) 0.75
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma. Adv Ther (2016) 0.75
Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial. BMC Ophthalmol (2014) 0.75
Anti-vascular endothelial growth factor in age-related macular degeneration: puzzle or a silent beginning! Indian J Ophthalmol (2013) 0.75
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ (2011) 6.19
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA (2007) 5.02
Thiazolidinediones and heart failure: a teleo-analysis. Diabetes Care (2007) 3.62
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ (2009) 3.18
Have online international medical journals made local journals obsolete? PLoS Med (2006) 2.64
Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med (2013) 2.59
Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol (2007) 2.44
Do educational interventions improve prescribing by medical students and junior doctors? A systematic review. Br J Clin Pharmacol (2009) 2.33
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med (2011) 2.06
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ (2005) 2.03
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med (2009) 1.86
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis. Br J Clin Pharmacol (2014) 1.82
Adverse drug reactions: keeping up to date. Fundam Clin Pharmacol (2002) 1.81
Five steps to conducting a systematic review. J R Soc Med (2003) 1.64
Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr (2012) 1.62
A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg (2007) 1.55
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology (2006) 1.52
Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol (2009) 1.51
Successful treatment of cystoid macular edema with valdecoxib. J Cataract Refract Surg (2007) 1.50
Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol (2004) 1.49
The National Institutes of Health and guidance for reporting preclinical research. BMC Med (2015) 1.48
Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines. PLoS One (2013) 1.48
Tiotropium and the risk of death in COPD. N Engl J Med (2014) 1.46
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med (2012) 1.45
Association between research sponsorship and study outcome in plastic surgery literature. Ann Plast Surg (2009) 1.45
Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med (2010) 1.44
A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard. PLoS One (2012) 1.38
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol (2008) 1.33
Light emitting diode microscope illumination for green fluorescent protein or fluorescein isothiocyanate epifluorescence. Biotechniques (2005) 1.29
The new CONSORT statement. BMJ (2010) 1.25
Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update. Curr Opin Pulm Med (2010) 1.24
Inflation of type I error rate in two statistical tests for the detection of publication bias in meta-analyses with binary outcomes. Stat Med (2002) 1.23
Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol (2007) 1.22
Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ (2011) 1.19
Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open (2011) 1.19
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review. Curr Opin Ophthalmol (2010) 1.16
Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis. J Vasc Surg (2009) 1.10
Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J Histochem Cytochem (2007) 1.10
Scientific value of systematic reviews: survey of editors of core clinical journals. PLoS One (2012) 1.09
National and multinational prospective trial registers. Lancet (2008) 1.09
Distribution of country of origin in studies used in Cochrane Reviews. PLoS One (2011) 1.07
Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials (2012) 1.04
[Planning, implementation and evaluation of cancer screening programs]. Z Arztl Fortbild Qualitatssich (2007) 1.03
Are pediatric Open Access journals promoting good publication practice? An analysis of author instructions. BMC Pediatr (2011) 1.03
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 1.02
Mediational effects of self-efficacy dimensions in the relationship between knowledge of dengue and dengue preventive behaviour with respect to control of dengue outbreaks: a structural equation model of a cross-sectional survey. PLoS Negl Trop Dis (2013) 1.02
Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf (2006) 1.02
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax (2012) 1.02
Detecting, quantifying and adjusting for publication bias in meta-analyses: protocol of a systematic review on methods. Syst Rev (2013) 1.00
The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004. BMC Med Res Methodol (2006) 0.98
[The PRISMA Statement - what should be reported about systematic reviews?]. Dtsch Med Wochenschr (2009) 0.98
Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011. J Clin Epidemiol (2013) 0.98
Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework. Syst Rev (2013) 0.96
Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for surgical treatment of chronic pancreatitis: a systematic review and meta-analysis. Ann Surg (2008) 0.95
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion. Am J Ophthalmol (2011) 0.94
The safety of rosiglitazone in the treatment of type 2 diabetes. Expert Opin Drug Saf (2008) 0.93
The performance of adverse effects search filters in MEDLINE and EMBASE. Health Info Libr J (2012) 0.93
Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. Am J Infect Control (2004) 0.93
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev (2011) 0.93
[The German Program for Disease Management Guidelines: CHD Guideline 2006. Short review]. Med Klin (Munich) (2006) 0.93
Call for worldwide withdrawal of tiotropium Respimat mist inhaler. BMJ (2012) 0.92
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev (2014) 0.92
The contribution of handsearching European general health care journals to the Cochrane Controlled Trials Register. Eval Health Prof (2002) 0.92
Nearly half of dental randomized controlled trials published in German are not included in Medline. Eur J Oral Sci (2002) 0.92
Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement. J Clin Epidemiol (2011) 0.92
Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. Exp Eye Res (2007) 0.92
[The German program for disease management guidelines. Background, methods, and development process]. Med Klin (Munich) (2006) 0.92
A test for publication bias in meta-analysis with sparse binary data. Stat Med (2007) 0.91
Comparison of search strategies in systematic reviews of adverse effects to other systematic reviews. Health Info Libr J (2014) 0.90
Do journals publishing in the field of urology endorse reporting guidelines? A survey of author instructions. Urol Int (2011) 0.90
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis. Thorax (2011) 0.89
Development of learning outcomes for an undergraduate prescribing curriculum (British Pharmacological Society prescribing initiative). Br J Clin Pharmacol (2010) 0.89
Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina (2010) 0.89
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. Cochrane Database Syst Rev (2014) 0.89
Sensitivity and precision of adverse effects search filters in MEDLINE and EMBASE: a case study of fractures with thiazolidinediones. Health Info Libr J (2011) 0.89
Unpublished data can be of value in systematic reviews of adverse effects: methodological overview. J Clin Epidemiol (2010) 0.88
Evidence-based plastic surgery: controlled trials in three plastic surgical journals (1990 to 2005). Ann Plast Surg (2009) 0.88
Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy. Acta Ophthalmol (2011) 0.88
Effectiveness of early in comparison to late(r) treatment in children with amblyopia or its risk factors: a systematic review. Ophthalmic Epidemiol (2010) 0.87
Retinal vascular occlusions: an interdisciplinary challenge. Dtsch Arztebl Int (2008) 0.87
The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients. BMJ Open (2012) 0.86
Inhaled corticosteroids in patients with chronic obstructive pulmonary disease. JAMA (2009) 0.86
Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev (2016) 0.86
Overall similarity and consistency assessment scores are not sufficiently accurate for predicting discrepancy between direct and indirect comparison estimates. J Clin Epidemiol (2012) 0.86